| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/09273948.2016.1151897 |
| P698 | PubMed publication ID | 27070178 |
| P2093 | author name string | Denis Wakefield | |
| Gerhild Wildner | |||
| Peter McCluskey | |||
| Stephan Thurau | |||
| P2860 | cites work | Understanding alterations in drug handling with aging: a focus on the pharmacokinetics of maintenance immunosuppressants in the elderly | Q38540776 |
| Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes | Q38938313 | ||
| Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis | Q40597607 | ||
| Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years | Q40639756 | ||
| Treatment of cystoid macular edema secondary to chronic non-infectious intermediate uveitis with an intraocular dexamethasone implant | Q41084180 | ||
| One-Year Outcomes of the SAVE Study: Sirolimus as a Therapeutic Approach for UVEitis | Q41429564 | ||
| The Standardization of Uveitis Nomenclature (SUN) Project. Development of a clinical evidence base utilizing informatics tools and techniques | Q44635152 | ||
| Measurement of neopterin, TGF-β1 and ACE in the exhaled breath condensate of patients with sarcoidosis | Q44653249 | ||
| Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis | Q46074801 | ||
| The WHO quality of life assessment instrument (WHOQOL-Bref): the importance of its items for cross-cultural research | Q47581385 | ||
| Vision-related quality of life and employment status in patients with uveitis of working age: a prospective study | Q48445350 | ||
| Rheumatoid arthritis: 2014 treat-to-target RA recommendations--strategy is key. | Q50953026 | ||
| Quality of life in patients with uveitis on chronic systemic immunosuppressive treatment. | Q51565090 | ||
| A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States. | Q53170505 | ||
| Reliability revisited: Autonomic responses in the context of everyday well-being | Q59200492 | ||
| New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors | Q26800937 | ||
| Identification of possible pathogenic pathways in Behçet's disease using genome-wide association study data from two different populations | Q30852088 | ||
| Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort | Q31029490 | ||
| Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study | Q33321092 | ||
| Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis | Q33629946 | ||
| Sensitivity of laser flare photometry compared to slit-lamp cell evaluation in monitoring anterior chamber inflammation in uveitis | Q33649946 | ||
| Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis | Q33903368 | ||
| What is new HLA-B27 acute anterior uveitis? | Q34172654 | ||
| The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics | Q34286402 | ||
| Autoimmune and autoinflammatory mechanisms in uveitis | Q34294964 | ||
| Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study | Q34444734 | ||
| Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy | Q34472219 | ||
| The balance of Th1/Th2 cytokines in rheumatoid arthritis | Q34506511 | ||
| Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis | Q34996471 | ||
| Quality-of-life metrics in pediatric uveitis. | Q35146629 | ||
| Uveitis in the elderly--is it easy to identify the masquerade? | Q35298517 | ||
| Scale for photographic grading of vitreous haze in uveitis | Q35563918 | ||
| Acute anterior uveitis and HLA-B27. | Q36168761 | ||
| Use of laser flare photometry to assess and monitor inflammation in uveitis | Q36845196 | ||
| Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy? | Q36964382 | ||
| International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). | Q37544507 | ||
| Clinical review: Update on treatment of inflammatory macular edema | Q37804876 | ||
| The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques | Q37841238 | ||
| Characteristics of uveitis presenting for the first time in the elderly: analysis of 91 patients in a tertiary center | Q37902653 | ||
| Interferon-α therapy in noninfectious uveitis | Q38003886 | ||
| Treatment of severe inflammatory eye disease in patients of reproductive age and during pregnancy | Q38012490 | ||
| Novel mechanisms of action of the biologicals in rheumatic diseases. | Q38076350 | ||
| Corticosteroid intravitreal implants vs. ranibizumab for the treatment of vitreoretinal disease | Q38091895 | ||
| Genetics of Behçet's disease: lessons learned from genomewide association studies | Q38164505 | ||
| Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study | Q38259825 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 122-133 | |
| P577 | publication date | 2016-04-12 | |
| P1433 | published in | Ocular Immunology and Inflammation | Q15760486 |
| P1476 | title | Unmet Needs and Future Directions in Inflammatory Eye Disease | |
| P478 | volume | 25 |
| Q89365929 | Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement | cites work | P2860 |
Search more.